ID   CS2-Cl26
AC   CVCL_D3FJ
SY   CS2 clone 26
DR   Wikidata; Q127380651
RX   PubMed=36744062;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a Superfolder GFP (sfGFP) construct was inserted at the C-terminal end of PLP1 (PubMed=36744062).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36744062
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,14
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 16,24
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 8,9
ST   D8S1179: 15
ST   FGA: 20,22.2
ST   Penta D: 9,13
ST   Penta E: 13,18
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3FI ! CS2PFYiCTR-nxx
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=36744062; DOI=10.3389/fncel.2022.1094291; PMCID=PMC9893511;
RA   Romero J.C., Berlinicke C.A., Chow S., Duan Y.-K., Wang Y.-F.,
RA   Chamling X., Smirnova L.;
RT   "Oligodendrogenesis and myelination tracing in a
RT   CRISPR/Cas9-engineered brain microphysiological system.";
RL   Front. Cell. Neurosci. 16:1094291.1-1094291.17(2022).
//